Matinas Biopharma Holdings, Inc
MTNB
Last
$2.87
Day
+1.4%
1y
-89.9%
5y
-99.7%
52w
-90.2%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0929d
EMA 21
2.77
EMA 50
3.51
EMA 200
8.45
20d high
-10.2%
5y high
-99.7%
5y range
0th
Positions held
Your positionsMTNB isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
6
Hold
watch
Signal
Neutral
Target
$3.43
Stop
$2.33
Stop distance
18.8%
Target vs last
+19.5%
Fundamentals
| Market cap | $2.77M | Enterprise value | $2.02M | Trailing P/E | — | Forward P/E | -0.94 |
| PEG | — | Price / book | 0.67 | Beta | 2.08 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -141.2% | ROA | -56.2% | Debt / equity | 0.00 |
| Current ratio | 0.85 | Free cash flow | -$2.45M | Analyst recommendation | none | Mean target | — |
| 52w high | $28.95 | 52w low | $2.27 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$1.3M | -$1.9M | -$1.9M | -$1.5M | -$5.2M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$1.6M | -$1.9M | -$1.6M | -$1.6M | -$1.8M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $1.1M | $3.2M | — |
| Op margin | — | — | -2168.4% | -771.3% | — |
| Net income | -$10.3M | -$24.3M | -$22.9M | -$21.0M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$7.0M | -$20.2M | -$23.8M | -$24.6M | — |
Headline scan
Headline risk — review
• [CRITICAL · listing] Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
News
Price (daily)
Full chart · RSI · MACD · patternsMTNB · daily+6.6% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin